HealthTech Startup OneOme Pursues $5m Financing Round

Minneapolis-based healthtech startup OneOme is raising a $5m debt round with $100k claimed, according to new SEC disclosure.

Formed and launched in 2014, OneOme is the product of a collaboration between Invenshure and the Mayo Clinic to provide physicians with fast and affordable personalized pharmacogenomic reports for patients to better match prescription medication with DNA.

Last fall, OneOme closed on a similar sized round, $5.25m, and began scaling sales; at last check, the service was rapidly expanding geographic availability, touching every state except New York.   It is estimated that OneOme has now received $8m+ in capitalization to date, though CEO Paul Owen declined to comment on things at this time.


Big Data Genomics Startup OneOme Quietly Raises More Cash
Mayo and Invenshure launch genomics platform Oneome